UN Photo/Christopher Black Events | 01 February 2023 MSF statements at WHO Executive Board 152nd session 1 min UN Photo/Christopher Black UN Photo/Christopher Black MSF representatives will speak at the 152nd session of the WHO Executive Board (EB) on a number of topics. Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min Statement | 01 February 2023 Diagnostics MSF Statement on EB152/5 - Strengthening diagnostics capacity 1 min Don't miss out! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -EventsIssue briefLetterPress releaseSpeechStatement Statement | 23 January 2017 Research and development 140th WHO EB - Intervention - Agenda Item 7.1 Health Emergencies and WHO Reform: A reality check Statement | 22 January 2017 140th WHO EB - Intervention - Agenda Item 8.5 2 min Statement | 01 February 2016 138th WHO EB - Addressing the global shortages of medicines, and the safety and accessibility of chidren’s medication Statement | 29 January 2016 Research and development 138th WHO EB - Agenda Item 10.3: Follow-up of the report of the CEWG on R&D Statement | 28 January 2016 Antimicrobial resistance 138th WHO EB - Agenda Item 8.5: Global Action Plan on Antimicrobial Resistance Statement | 27 January 2016 Hepatitis C 138th WHO EB - Agenda Item 9.2. Draft Global Health sector strategies Statement | 26 January 2016 Research and development 138th WHO EB - Agenda Item 9.1: Sharing on diagnostic, preventive and therapeutic products Photograph by WHO/Pierre Albouy Press release Press release | 25 May 2015 Vaccines Governments take decisive step over vaccine prices Load More
Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
Statement | 01 February 2023 Diagnostics MSF Statement on EB152/5 - Strengthening diagnostics capacity 1 min
Statement | 23 January 2017 Research and development 140th WHO EB - Intervention - Agenda Item 7.1 Health Emergencies and WHO Reform: A reality check
Statement | 01 February 2016 138th WHO EB - Addressing the global shortages of medicines, and the safety and accessibility of chidren’s medication
Statement | 29 January 2016 Research and development 138th WHO EB - Agenda Item 10.3: Follow-up of the report of the CEWG on R&D
Statement | 28 January 2016 Antimicrobial resistance 138th WHO EB - Agenda Item 8.5: Global Action Plan on Antimicrobial Resistance
Statement | 27 January 2016 Hepatitis C 138th WHO EB - Agenda Item 9.2. Draft Global Health sector strategies
Statement | 26 January 2016 Research and development 138th WHO EB - Agenda Item 9.1: Sharing on diagnostic, preventive and therapeutic products
Photograph by WHO/Pierre Albouy Press release Press release | 25 May 2015 Vaccines Governments take decisive step over vaccine prices
